Search Results - "Assouad, R"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Impact of an adaptive program for cognitive and emotional deficits (ADACOG program) in multiple sclerosis patients with cognitive impairments by Pineau, F., Socha, J., Corvol, J.-C., Louapre, C., Assouad, R., Maillart, E., Lubetzki, C., Papeix, C.

    Published in Revue neurologique (01-05-2019)
    “…Cognitive impairment is frequent in multiple sclerosis (MS), affecting approximately 40 to 70% of patients. We developed a psycho-educational program (ADACOG…”
    Get full text
    Journal Article
  2. 2

    Current treatment of multiple sclerosis by Gout, O, Bensa, C, Assouad, R

    Published in La revue de medecine interne (01-08-2010)
    “…Since commercialisation of the first immunomodulatory drug (IMD) for multiple sclerosis (subcutaneous interferon beta-1b) in 1995, three new IMD have been on…”
    Get full text
    Journal Article
  3. 3

    Actualités thérapeutiques de la sclérose en plaques by Gout, O., Bensa, C., Assouad, R.

    Published in La revue de medecine interne (01-08-2010)
    “…Depuis la commercialisation d’un premier immunomodulateur (interféron β-1b) en 1995, trois nouveaux immunomodulateurs ont été commercialisés pour le traitement…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Experience of an out-patient multidisciplinary approach in disabled patients with multiple sclerosis by Papeix, C, Charles, P, Kopf, A, Youssov, K, Mailhan, L, Assouad, R, Stankoff, B, Lyon-Caen, O, Lubetzki, C

    Published in Multiple sclerosis (01-09-2008)
    “…Background: In our multiple sclerosis (MS) clinic, we propose to treat disabled patients with an outpatient multidisclplinary approach (OMA) by a team composed…”
    Get full text
    Journal Article
  7. 7

    Quantification of neuronal loss in progressive multiple sclerosis: a positron emission tomography study with [11C]-flumazenil by Stankoff, B, Leroy, C, Sureau, F, Delforge, J, Assouad, R, Tourbah, A, Galanaud, D, Papeix, C, Comtat, C, Lubetzki, C, Trebossen, R, Bottlaender, M

    Published in Multiple sclerosis (01-09-2008)
    “…Background: It is now well admitted that neuronal injury plays a crucial role in the appearance and progression of neurological disability in multiple…”
    Get full text
    Journal Article
  8. 8

    Psychiatric and cognitive onset in multiple sclerosis by Assouad, R, Louapre, C, Tourbah, A, Papeix, C, Sedel, F, Benoit, N, Galanaud, D, Lehericy, S, Fontaine, B, Lyon-Caen, O, Lubetzki, C, Stankoff, B

    Published in Multiple sclerosis (01-09-2008)
    “…Background: Psychiatric and cognitive symptoms are rarely reported as the first manifestation of multiple sclerosis (MS). Objective: To describe clinical and…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Hearing loss in multiple sclerosis: clinical, electrophysiologic and radiological study by de Seze, J, Assouad, R, Stojkovic, T, Desaulty, A, Dubus, B, Vermersch, P

    Published in Revue neurologique (01-11-2001)
    “…Clinical presentation of multiple sclerosis (MS) is highly heterogeneous. Deafness is considered to be rare. The aim of this study was to determine the…”
    Get more information
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14